5paisa Capital-Giskard Deal: ₹121.57 Cr Terms in 2026

The announcement and why it matters

5paisa Capital Ltd has approved the acquisition of Giskard Datatech Private Limited (Giskard) in a transaction valued at up to ₹121.57 crore (₹1,21,57,49,108). The board cleared the proposal at its meeting held on July 28, 2026, with the company disclosing the outcome under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. 5paisa said the acquisition is intended to strengthen its digital investment ecosystem by adding advanced data analytics and AI-enabled research capabilities. The transaction is structured as a combination of cash consideration and a share swap, with a preferential issue of new 5paisa equity shares to certain Giskard shareholders. If completed, Giskard will become a wholly owned subsidiary of 5paisa, subject to approvals and execution of definitive documents. The company has also indicated that regulatory approval from SEBI is required because Giskard holds a Research Analyst registration. Alongside regulatory clearances, 5paisa will seek shareholder approval through a postal ballot.

What 5paisa is buying

The proposed acquisition covers 100% of Giskard’s equity share capital through a composite transaction. 5paisa described Giskard as a business focused on software development, data processing, and analytics. The stated objective is to integrate AI-driven tools and data analytics capabilities into 5paisa’s broader product and platform stack. From a disclosure perspective, the key operational outcome is a change in ownership, with Giskard becoming a wholly owned subsidiary after completion. The company has not provided integration timelines beyond the overall deal completion estimate, but it has flagged that implementation depends on approvals and completion documentation. Importantly, the requirement for SEBI’s prior approval is linked to Giskard’s Research Analyst registration, which introduces an additional regulatory step compared with typical technology acquisitions.

Deal size and headline consideration

The aggregate consideration is capped at ₹121.57 crore (₹1,21,57,49,108) and is being settled through cash and issuance of 5paisa shares. 5paisa’s disclosure frames this as an “aggregate consideration” comprising the cash payout and consideration through equity issuance under the share swap. The transaction documents referenced include a Shareholders’ Cum Purchase Agreement (SCPA) and a Share Purchase Agreement (SPA) proposed to be executed among relevant parties. The company also stated that the valuation of Giskard’s equity shares was determined using the Discounted Cash Flow method, as set out in valuation documentation by an independent registered valuer (IBBI/RV/06/2025/15965). Based on this valuation, each Giskard equity share was valued at ₹11,794 as of June 18, 2026.

How the cash component works

Under the approved structure, 5paisa proposes to acquire up to 1,03,082 equity shares of Giskard, representing 58.68% of Giskard’s diluted paid-up equity share capital, for an aggregate cash consideration not exceeding ₹1,21,57,49,108. The company’s disclosure also notes a commercial requirement that the cash component be paid immediately. To facilitate this immediate payment and enable timely completion, the promoters of 5paisa expressed willingness to acquire certain shares of Giskard directly from existing Giskard shareholders against payment of the cash consideration, as may be decided by the board. This arrangement, as described, is positioned as an execution support mechanism for the cash leg of the transaction.

Share swap and preferential issue details

The remaining stake is proposed to be acquired through issuance of 5paisa equity shares on a preferential basis for consideration other than cash. Specifically, up to 66,148 Giskard equity shares, representing 37.65% of Giskard’s diluted paid-up equity share capital, will be acquired through a share swap arrangement. 5paisa will issue 20,50,588 equity shares under this preferential issue on a private placement basis. The exchange ratio disclosed is 1:31, meaning eligible Giskard shareholders will receive 31 equity shares of 5paisa for every one share held in Giskard. The company also clarified that fractional entitlements under the swap will be settled in cash.

Identified allottees for the preferential issue

The disclosures state that the preferential issue of 20,50,588 shares will be made to Giskard shareholders, including Amber Pabreja and Devi Yeshodharan. The company’s table on the swap provides specific details for Mr. Amber Pabreja, showing 38,148 Giskard shares available for swap and an allotment of 11,82,588 5paisa shares. The same table lists Ms. Yeshodharan with 28,000 Giskard shares available for swap, while also noting that the total preferential issue shares add up to 20,50,588. The company has also reiterated that any balance shares that cannot be swapped due to the determined ratio would be paid out in cash.

Approvals, filings, and the postal ballot route

5paisa has stated that the acquisition is contingent on receipt of necessary corporate, statutory, and regulatory approvals. A key approval is SEBI’s prior consent, given Giskard’s Research Analyst registration. For shareholder approval, 5paisa will conduct a postal ballot in compliance with Regulation 30 and the referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The board has approved the draft postal ballot notice dated July 28, 2026, and the company said the notice will be submitted to stock exchanges in due course. These steps indicate that the company is sequencing approvals and disclosures formally before closing.

Expected timeline for completion

5paisa has indicated a completion timeline of up to six months, subject to approvals. The six-month estimate effectively makes the pace of regulatory clearance and the shareholder postal ballot the main near-term procedural milestones. The company has not indicated any alternative closing structure if approvals take longer, but it has made clear that the acquisition will only complete after requisite approvals and definitive documentation. Given SEBI’s involvement due to the Research Analyst registration, investors tracking the transaction will likely focus on the regulatory process and the shareholder vote timeline.

Key deal terms at a glance

Market impact and what to monitor

The disclosed impact is strategic and operational, rather than immediate financial performance, because the announcement focuses on acquisition terms and process steps. From an investor perspective, the key market-relevant points in the disclosure are the issuance of 20,50,588 new 5paisa shares through a preferential allotment, and the need for shareholder approval via postal ballot. The regulatory angle matters because SEBI approval is specifically required due to Giskard’s Research Analyst registration, creating a clear gating item before closing. The company has also described how the cash component is intended to be paid immediately, and that promoters may directly acquire certain Giskard shares to facilitate timely payment, subject to board decisions. Separately, the share swap includes cash settlement for fractional entitlements, which clarifies how non-round exchange outcomes will be handled. The company’s up-to-six-month timeline makes the progress of filings, approvals, and the postal ballot outcome the principal near-term watchpoints.

Why the structure is notable

The acquisition is structured to combine immediate cash for a majority portion of the target’s diluted capital with a preferential share issuance for a large minority portion. The 1:31 swap ratio and the explicit disclosure of fractional settlement mechanics reduce uncertainty around how the share swap will be executed. The disclosed valuation of ₹11,794 per Giskard share, determined through a DCF method by an independent registered valuer, provides context for how consideration has been benchmarked in the transaction documents. The reliance on SEBI approval, tied to the Research Analyst registration, is a reminder that acquisitions in the broking and research ecosystem can include regulatory dependencies beyond the Companies Act process. Finally, the postal ballot route for shareholder approval signals that the company is treating the acquisition and preferential issue as items requiring explicit shareholder consent under applicable rules.

Closing view

5paisa Capital’s board has approved the acquisition of Giskard Datatech for up to ₹121.57 crore through a cash-and-share-swap structure, with 20,50,588 new 5paisa shares proposed under a preferential issue at a 1:31 exchange ratio. The next steps are procedural but critical: shareholder approval through the postal ballot and regulatory approvals, including SEBI’s prior approval due to Giskard’s Research Analyst registration. The company has indicated the transaction could complete within up to six months, subject to these clearances and completion documentation.